This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Chinese Academy of Medical Sciences. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovative Contributions of Dongmei Wang
Introduction
Dongmei Wang is a prominent inventor based in Beijing, China. She has made significant contributions to the field of medical science, particularly in vaccine development. Her innovative work has led to the creation of a unique recombinant chemokine-antigen vaccine.
Latest Patents
Dongmei Wang holds 1 patent for her invention titled "Recombinant chemokine-antigen vaccine." This patent involves a recombinant gene sequence that comprises the human SLC gene, an antigen gene, and an IgG1-Fc fragment gene. The SLC gene is linked upstream to the antigen gene, while the IgG1-Fc fragment is linked downstream to the antigen gene. This invention also relates to the application of the recombinant gene sequence in the preparation of gene vaccines.
Career Highlights
Dongmei Wang is affiliated with the Chinese Academy of Medical Sciences, where she conducts her research and development work. Her role at this esteemed institution has allowed her to focus on groundbreaking innovations in the medical field.
Collaborations
Some of her notable coworkers include Xiao Bi Liang and Wenbo Ma, who have collaborated with her on various projects.
Conclusion
Dongmei Wang's contributions to vaccine development exemplify the impact of innovative research in medical science. Her work continues to inspire advancements in the field and holds promise for future medical breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile